Swabian Instruments (Germany)

Abstract Thermoelectric transport is widely used to study Abrikosov vortex dynamics in unconventional superconductors. However, only a few thermoelectric studies have been conducted near the dimensional crossover that occurs when the vortex‐vortex interaction length scale becomes comparable to the sample size. Here, the effects of finite size on the dissipation mechanisms of the Nernst effect in the optimally doped Bi2Sr2CaCu2O8 + x high‐temperature superconductor are reported, down to the atomic length limit. To access this regime, a new generation of thermoelectric chips based on silicon nitride microprinted circuit boards is developed. These chips ensure optimized signals while preventing sample deterioration. The results demonstrate that lateral confinement at the nanoscale can effectively reduce vortex dissipation. Investigating vortex dissipation at the micro‐ and nano‐scale is essential for creating stable, miniaturized superconducting circuits.

In most practices, clinics and professional societies, a homozygous H63D gene mutation was and is generally considered relatively harmless, since carriers of this mutation very rarely develop classic ferritin-related hemochromatosis. Ferritin levels are usually normal or even rather low in these patients, so everything seems fine. Due to the fragmentation of medicine into many specialties, on a meta-level, hardly anyone has noticed that people with a homozygous H63D mutation can develop a very severe disease, H63D Syndrome. The key to understanding the phenotype is non- transferrin-bound iron, or NTBI. H63D Syndrome is a separate phenotype (clinical picture) of a homozygous mutation of the HFE gene H63D, which is otherwise known to cause at best a mild classical hemochromatosis. H63D syndrome, however, is not just another type of hemochromatosis, it is a serious syndrome caused by non- transferrin bound iron (NTBI) which is the result of an elevated transferrin saturation (50-100%) due to hypotransferrinemia which is the consequence of a homozygous mutation of HFE gene H63D.

H63D Syndrome is a genetic disorder characterized by iron accumulation in the body, which has been historically associated with hereditary hemochromatosis (HH). However, recent research has provided evidence that this syndrome, particularly type-1 H63D, has less in common with HH than with other metal accumulation diseases such as Wilson's Disease. This paper aims to elucidate the distinct features of H63D Syndrome, emphasizing the differences between H63D and HH, as well as the unique challenges associated with its treatment. Furthermore, we will explore the role of non-transferrin-bound iron (NTBI) in the pathophysiology of H63D Syndrome and its implications on cellular function and heart health.

<p>H63D-Syndrome, a genetic disorder resulting from the HFE H63D gene mutation, is associated with increased risks of iron overload and subsequent multi-organ damage. Recent evidence suggests that the heart may be particularly susceptible to damage in patients with H63D-Syndrome due to the affinity of non-transferrin bound iron (NTBI) to sodium, potassium, and calcium channels. This paper aims to review the current understanding of H63D-Syndrome, its effects on cardiac function, and the necessity of regular heart monitoring in individuals diagnosed with this condition.</p>

A superconducting nanowire single-photon detector was utilized to enable fast time-domain diffuse correlation spectroscopy to measure cerebral blood flow in adult brain separating early and late photons.